“

One of the things that we believe makes our vaccine unique is that we actually see really good immune response against variants with our prototype vaccine. And so, if you think about the vaccine that we already have authorized that we're talking about now to be authorized for adolescents, we actually see a good immune response against variants including Omicron, including BA.1 and BA.5.